Feb 3 (Reuters) - Mesoblast Ltd MSB.AX :
* SUBMITTED ITS COMPLETED BIOLOGICS LICENSE APPLICATION TO UNITED STATES FDA FOR RYONCIL
Feb 3 (Reuters) - Mesoblast Ltd MSB.AX :
* SUBMITTED ITS COMPLETED BIOLOGICS LICENSE APPLICATION TO UNITED STATES FDA FOR RYONCIL